Siemens Atelllica IM Anti-Thyroid Peroxidase II (aTPOII) - HSA Registration DE0510185
Access comprehensive regulatory information for Siemens Atelllica IM Anti-Thyroid Peroxidase II (aTPOII) in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0510185 and owned by Siemens Healthcare Diagnostics Inc. The device was registered on December 30, 2024.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The Atellica® IM Anti-Thyroid Peroxidase II (aTPOII) assay is for in vitro diagnostic use in the quantitative measurement of autoantibodies against thyroid peroxidase in human serum and plasma (EDTA and lithium heparin) using the Atellica® Analyzers. Anti-thyroid peroxidase (aTPO) measurements are used, in conjunction with a clinical assessment, as an aid in the diagnosis of autoimmune thyroiditis.